Skip to Content

Analysts’ Average Recommendation for The Clorox Company (NYSE:CLX) is “Reduce.”

Analysts’ Average Recommendation for The Clorox Company (NYSE:CLX) is “Reduce.”

The fifteen brokerages currently covering shares of The Clorox Company (NYSE: CLX) have collectively given the stock a “reduce” recommendation, which Bloomberg.com identifies as the average recommendation for the stock. In addition, nine experts have rated the company as having a “sell” recommendation, four experts have rated it as having a “hold” rating, and one expert has rated it as having a “buy” recommendation. The $136.17 represents the mean one-year target price established by analysts who have covered the stock in the preceding year. In addition, these analysts have provided their predictions for the stock’s price in the following year.
Recently, CLX has gained access to information that several brokerage firms previously held. In a research note published on November 2, Morgan Stanley increased their target price for Clorox from $130.00 to $142,000 and categorized the stock as “equal weight.” In a research note published on November 2 by Credit Suisse Group, the price target for Clorox was increased from $130.00 to $135.00. The increase came about as a result of the research note. Despite this, the company continued to hold its “underperform” rating on its shares. UBS Group gave Clorox a “sell” rating in a research note published on November 2. The note stated that the firm had increased its price objective for the stock from $119.00 to $129.00. The “sell” rating assigned to the stock was another point of emphasis in the research note. The research note issued by Bank of America on September 14 contained an announcement that the bank would begin covering Clorox. As a result, they gave the stock an “underperform” rating. The price target that Wells Fargo & Company has set for Clorox shares has increased from $125.00 to $135.00 due to a research note published on Tuesday, January 3. In addition, they changed Clorox’s rating from “underweight” to “neutral,” reflecting their more positive outlook on the company.
Several hedge funds and other institutional investors have adjusted how they invest in the company over the past few months. During the first three months of this year, Vanguard Group Inc. increased the percentage of Clorox stock held by 1.3%. Following purchasing an additional 185,012 shares during the most recent period, Vanguard Group Inc. now has 14,685,046 shares of the company’s stock, which are currently valued at $2,041,661,000. These shares were added to the company’s holdings. During the third quarter, BlackRock Inc. increased the amount of Clorox stock owned by 5.6%, bringing the total to 100%. BlackRock Inc. now has a total ownership stake in the company equal to 10,964,049 shares after purchasing an additional 580,982 shares during the most recent period for a total investment of $1,407,673,000. This brings the company’s total number of shares to 10,964,049; during the second quarter, the State Street Corporation achieved a 9.6% increase in the proportion of Clorox stock it owned. State Street Corp. now owns a total of 8,907,083 shares of the company following the purchase of an additional 778,269 shares during the most recent trading session. The value of State Street Corp.’s holdings in the company at present is $1,255,721,000. During the second quarter, Wells Fargo & Company MN increased the percentage of Clorox stock owned by 2.4%. Wells Fargo & Company MN now owns 3,557,161 shares of the corporation, which have a value of $501,489,000, after purchasing an additional 82,698 shares during the most recent reporting period. This brings the total number of shares owned by the company to 3,557,161. Lastly, but certainly not least, during the third quarter, Federated Hermes Inc. increased the percentage of Clorox stock it held in its portfolio by 11.1%. After making additional purchases totaling 215,425 shares throughout the quarter, Federated Hermes Inc. now holds 2,161,323 shares of the company’s stock in its portfolio. There are 277,492,000 shares outstanding, which gives the company a market value of $277,492,000. Institutions own the company’s stock 79.12% of the time, making them the most common shareholder.
On Friday, shares of NYSE: CLX started trading for $144.44 each. The price of Clorox can be found anywhere on the market between its 52-week low of $120.50 and its 52-week high of $186.86. The company has a market capitalization of $17.82 billion, the price-to-earnings ratio is 44.31, the price-to-earnings-to-growth ratio is 2.97, and the beta value is 0.31. The stock price is $142.92 when calculated using the moving average of the previous 200 days, but it is $145.35 using the moving average of the most recent 50 days. A debt-to-equity ratio comes in at 4.99; a quick ratio comes in at 0.50; a current ratio comes in at 0.88; and a quick ratio comes in at 0.50.
On November 1, the most recent quarterly earnings report for Clorox, traded on the NYSE under the symbol CLX, was made public. The company’s earnings per share (EPS) for the quarter came in at $0.93, an increase of $0.20 over the consensus estimate of $0.73. This indicates that the company is performing better than expected. Despite having a net margin of only 5.75 percent, Clorox could generate a return on equity of 83,000%. In addition, the revenue for the quarter came in at $1.74 billion, which was significantly higher than the analysts’ average estimate of $1.69 billion for the amount of revenue generated during the quarter. According to the projections made by analysts for the current financial year, Clorox should generate earnings of $4.11 per share for the company’s operations.
In addition, the corporation has announced a quarterly dividend, which will be paid out on February 10. This date is currently scheduled. Shareholders who are “on record” as of January 25 will be eligible to receive a $1.18 dividend payment per share. The dividend must be paid out by Tuesday, January 24, a business day. This translates to a yield of 3.27% and a dividend payment of $4.72 yearly for each shareholder. Clorox returns 144.79% of total earnings to shareholders as dividends.
The Clorox Company is involved in producing and distributing its goods globally, serving individual customers and business organizations. The business’s operations are divided into four distinct divisions: health and wellness, household, lifestyle, and international. Hidden Valley is a brand name that includes various products designed specifically for use in commercial kitchens and restaurants. Under RenewLife, Natural Vitality, and NeoCell, one can purchase various dietary supplements, including vitamins and minerals. Some brands that carry cleaning products, such as laundry additives and home care items, are Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409. Other brands that carry cleaning products include Formula 409. Scentiva and Formula 409 are two other examples of brands.

Tags

Leave a comment

Your email address will not be published. Required fields are marked *